The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study
Open accessAbstract
Background—: Heart failure caused by wild-type transthyretin amyloidosis (ATTRwt) is an underappreciated cause of morbidity and mortality in the aging population. The aims of this study were to examine features of disease and to characterize outcomes in a large ATTRwt cohort. Methods and Results—: Over 20 years, 121 patients with ATTRwt were enrolled in a prospective, observational study. Median age at enrollment was 75.6 years (range, 62.6–87.8 years); 97% of patients were white. The median survival, measured from biopsy diagnosis, was 46.69 months (95% confidence interval, 41.95–56.77); 78% of deaths were attributable to cardiac causes. By Kaplan–Meier analysis, 5-year survival was 35.7% (95% confidence interval, 25–46). Impaired functional capacity (mean V o 2 max, 13.5 mL·kg −1 ·min −1 ) and atrial fibrillation (67%) were common clinical features. Multivariate predictors of reduced survival were elevated serum brain natriuretic peptide (482±337 pg/mL) and uric acid (8.2±2.6 mg/dL), decreased left ventricular ejection fraction (50% median; range, 10%–70%), and increased relative wall thickness (0.75±0.19). Conclusions—: In this series of patients with biopsy-proven ATTRwt, poor functional capacity and atrial arrhythmias were common clinical features. Elevated brain natriuretic peptide and uric acid, decreased left ventricular ejection fraction, and increased relative wall thickness were associated with limited survival of only 35.7% at 5 years for the group as a whole. These data establish the natural history of ATTRwt, provide statistical basis for the design of future interventional clinical trials, and highlight the need for more sensitive diagnostic tests and disease-specific treatments for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,229
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelista, A. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.023 · Cited by 4,367
Recommendations for the evaluation of left ventricular diastolic function by echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelisa, A. (2008) · European Journal of Echocardiography · doi:10.1093/ejechocard/jep007 · Cited by 3,351 · cited 1×
“Stages of diastolic dysfunction were defined according to recommendations of the European and American societies for echocardiography.(18) LVWT was derived from an average of the interventricular septum and posterior WT.”
MethodKoren, M. J., Devereux, R. B., Casale, P. N., Savage, D. D., & Laragh, J. H. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-5-345 · Cited by 2,366
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,274
Balady, G. J., Arena, R., Sietsema, K., Myers, J., Coke, L., Fletcher, G. F., Forman, D., Franklin, B., Guazzi, M., Gulati, M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181e52e69 · Cited by 1,964
Bone metabolism and disease in chronic kidney disease
Eknoyan, G., Levin, A., & Levin, N. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00905-3 · Cited by 1,286
Safety and efficacy of RNAi therapy for transthyretin amyloidosis
Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208760 · Cited by 971
Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types
Rapezzi, C., Merlini, G., Quarta, C. C., Riva, L., Longhi, S., Leone, O., Salvi, F., Ciliberti, P., Pastorelli, F., Biagini, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843334 · Cited by 774
Self-citationRepurposing Diflunisal for Familial Amyloid Polyneuropathy: A Randomized Clinical Trial
Berk, J. L., Suhr, O. B., Obici, L., Sekijima, Y., Zeldenrust, S. R., Yamashita, T., Heneghan, M. A., Gorevic, P. D., Litchy, W. J., Wiesman, J. F., et al. (2013) · JAMA · doi:10.1001/jama.2013.283815 · Cited by 708
Self-citationProgression of Left Ventricular Diastolic Dysfunction and Risk of Heart Failure
Kane, G. C., Karon, B. L., Mahoney, D. W., Redfield, M. M., Roger, V. L., Burnett, J. C., Jacobsen, S. J., & Rodeheffer, R. J. (2011) · JAMA · doi:10.1001/jama.2011.1201 · Cited by 682
Tanskanen, M., Peuralinna, T., Polvikoski, T., Notkola, I., Sulkava, R., Hardy, J., Singleton, A., Kiuru‐Enari, S., Paetau, A., Tienari, P. J., et al. (2008) · Annals of Medicine · doi:10.1080/07853890701842988 · Cited by 591
Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis
Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S.-I., Merlini, G., Saraiva, M. J. M., & Westermark, P. (2014) · Amyloid · doi:10.3109/13506129.2014.964858 · Cited by 508
Tabulation of human transthyretin (TTR) variants, 2003
Connors, L. H., Lim, A., Prokaeva, T., Roskens, V. A., & Costello, C. E. (2003) · Amyloid · doi:10.3109/13506120308998998 · Cited by 505
Self-citationFrequency and distribution of senile cardiovascular amyloid
Cornwell, G. G., Murdoch, W. L., Kyle, R. A., Westermark, P., & Pitkänen, P. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90443-6 · Cited by 483
Brenner, D. A., Jain, M., Pimentel, D. R., Wang, B., Connors, L. H., Skinner, M., Apstein, C. S., & Liao, R. (2004) · Circulation Research · doi:10.1161/01.res.0000126569.75419.74 · Cited by 450
Self-citationAerobic fitness norms for males and females aged 6 to 75 years: a review.
Shvartz, E., & Rc, R. (1990) · PubMed · Cited by 445
Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
Pinney, J. H., Whelan, C. J., Petrie, A., Dungu, J., Banypersad, S. M., Sattianayagam, P., Wechalekar, A., Gibbs, S. D. J., Venner, C. P., Wassef, N., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000098 · Cited by 372
Ng, B., Connors, L. H., Davidoff, R., Skinner, M., & Falk, R. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1425 · Cited by 367
Self-citationShimizu, G., Hirota, Y., Kita, Y., Kawamura, K., Saito, T., & Gaasch, W. H. (1991) · Circulation · doi:10.1161/01.cir.83.5.1676 · Cited by 345
Dispenzieri, A. A., Gertz, M. A., Kyle, R. A., Lacy, M. Q., Burritt, M. F., Therneau, T. M., McConnell, J. P., Litzow, M. R., Gastineau, D. A., Tefferi, A., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0390 · Cited by 320
Cardiac amyloidosis: the great pretender
Rapezzi, C., Lorenzini, M., Longhi, S., Milandri, A., Gagliardi, C., Bartolomei, I., Salvi, F., & Maurer, M. S. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9480-0 · Cited by 201
The premortem recognition of systemic senile amyloidosis with cardiac involvement
Kyle, R. A., Spittell, P. C., Gertz, M. A., Li, C.-Y., Edwards, W. D., Olson, L. J., & Thibodeau, S. N. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00229-x · Cited by 169
Merlini, G., Planté‐Bordeneuve, V., Judge, D. P., Schmidt, H., Obici, L. P., Perlini, S., Packman, J., Tripp, T. J., & Grogan, D. R. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9512-x · Cited by 141
Sakai, H., Tsutamoto, T., Tsutsui, T., Tanaka, T., Ishikawa, C., & Horie, M. (2006) · Circulation Journal · doi:10.1253/circj.70.1006 · Cited by 83
Left Ventricular Geometry and Mortality in Patients >70 Years of Age With Normal Ejection Fraction
Lavie, C. J., Milani, R. V., Ventura, H. O., & Messerli, F. H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.037 · Cited by 76
Prognostic value of left ventricular concentric remodeling in uncomplicated mild hypertension
Pierdomenico, S. D., Lapenna, D., Bucci, A., MANENTE, B., CUCCURULLO, F., & Mezzetti, A. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.06.016 · Cited by 67
Quotidian dialysis: the London, Ontario experience
Blagg, C. R. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00529-8 · Cited by 53
Fitch, N. J. S., Akbari, M. T., & Ramsden, D. B. (1991) · Journal of Endocrinology · doi:10.1677/joe.0.1290309 · Cited by 49
Impact of left ventricular geometry on prognosis-a review of ochsner studies.
Lavie, C. J., Milani, R. V., Shah, S. B., Gilliland, Y. E., Bernal, J. A., Dinshaw, H. K., & Ventura, H. O. (2008) · PubMed · Cited by 24
Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis
Perlini, S., Salinaro, F., Musca, F., Mussinelli, R., Boldrini, M., Raimondi, A., Milani, P., Foli, A., Cappelli, F., Perfetto, F., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000120 · Cited by 22
Self-citationMuiesan, M. L., Salvetti, M., Monteduro, C., Donato, F., Rizzoni, D., & Agabiti‐Rosei, E. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816080-00014 · Cited by 11
Cited by
Transthyretin Amyloid Cardiomyopathy
Ruberg, F. L., Grogan, M., Hanna, M., Kelly, J. W., & Maurer, M. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.003 · Cited by 1,112
Self-citationGrogan, M., Scott, C. G., Kyle, R. A., Zeldenrust, S. R., Gertz, M. A., Lin, G., Klarich, K. W., Miller, W. L., Maleszewski, J. J., & Dispenzieri, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.033 · Cited by 763
Castaño, A., Narotsky, D. L., Hamid, N., Khalique, O. K., Morgenstern, R., DeLuca, A., Rubin, J., Chiuzan, C., Nazif, T., Vahl, T., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx350 · Cited by 726
Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis
Maurer, M. S., Elliott, P., Comenzo, R., Semigran, M., & Rapezzi, C. (2017) · Circulation · doi:10.1161/circulationaha.116.024438 · Cited by 492
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths
González-López, E., Gagliardi, C., Dominguez, F., Quarta, C. C., de Haro-del Moral, F. J., Milandri, A., Salas, C., Cinelli, M., Cobo-Marcos, M., Lorenzini, M., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx043 · Cited by 376
Metadata
- Authors
- Connors, L. H., Sam, F., Skinner, M., Salinaro, F., Sun, F., Ruberg, F. L., Berk, J. L., & Seldin, D. C.
- Venue
- Circulation
- Published
- 2016-01-19
- Volume
- 133
- Issue
- 3
- Pages
- 282-290
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2254731646
- Cited by
- 324
- References
- 34
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.